News in brief - CNS disorders

  • Aripiprazole tablets are now available as a generic for the treatment of schizophrenia in adults.
  • Actavis has launched Sastravi (levodopa/carbidopa/entacapone) for the treatment of Parkinson's disease and end-of-dose motor fluctuations not stabilised with levodopa/dopa decarboxylase inhibitor.
  • Sanofi has discontinued Piportil Depot (pipotiazine palmitate) owing to a global shortage of the active ingredient. Supplies of the injection are expected to be exhausted by the end of March 2015.
  • Novartis has announced the discontinuation of Tegretol Chewtabs (carbamazepine). Selection of an alternative medication should be a clinical decision based on the individual patient's history.
  • The antiemetic domperidone (Motilium) will now be available only as a POM.
  • Scopoderm (hyoscine hydrobromide) patches can now be bought without a prescription from pharmacies for the treatment of travel sickness. Each 1.5mg patch can be used for up to 72 hours.
  • The NMDA antagonist memantine is now available as a generic tablet for the treatment of moderate to severe Alzheimer's dementia.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New guidance for minimising psychological impact of COVID-19 pandemic in primary care patients
Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

MIMS launches Respiratory and Allergy Learning webinars

MIMS launches Respiratory and Allergy Learning webinars

Join us for the 2020 Respiratory and Allergy Learning...